BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1303 related articles for article (PubMed ID: 33588991)

  • 1. Antimicrobial resistance and COVID-19: Intersections and implications.
    Knight GM; Glover RE; McQuaid CF; Olaru ID; Gallandat K; Leclerc QJ; Fuller NM; Willcocks SJ; Hasan R; van Kleef E; Chandler CI
    Elife; 2021 Feb; 10():. PubMed ID: 33588991
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Global geographic trends in antimicrobial resistance: the role of international travel.
    Frost I; Van Boeckel TP; Pires J; Craig J; Laxminarayan R
    J Travel Med; 2019 Dec; 26(8):. PubMed ID: 31115466
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of COVID-19: implications for antimicrobial resistance in Africa.
    Iwu CJ; Jordan P; Jaja IF; Iwu CD; Wiysonge CS
    Pan Afr Med J; 2020; 35(Suppl 2):119. PubMed ID: 33282074
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antimicrobial resistance research in a post-pandemic world: Insights on antimicrobial resistance research in the COVID-19 pandemic.
    Rodríguez-Baño J; Rossolini GM; Schultsz C; Tacconelli E; Murthy S; Ohmagari N; Holmes A; Bachmann T; Goossens H; Canton R; Roberts AP; Henriques-Normark B; Clancy CJ; Huttner B; Fagerstedt P; Lahiri S; Kaushic C; Hoffman SJ; Warren M; Zoubiane G; Essack S; Laxminarayan R; Plant L
    J Glob Antimicrob Resist; 2021 Jun; 25():5-7. PubMed ID: 33662647
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of the COVID-19 pandemic on the surveillance, prevention and control of antimicrobial resistance: a global survey.
    Tomczyk S; Taylor A; Brown A; de Kraker MEA; El-Saed A; Alshamrani M; Hendriksen RS; Jacob M; Löfmark S; Perovic O; Shetty N; Sievert D; Smith R; Stelling J; Thakur S; Vietor AC; Eckmanns T;
    J Antimicrob Chemother; 2021 Oct; 76(11):3045-3058. PubMed ID: 34473285
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antimicrobial Resistance, the COVID-19 Pandemic, and Lessons for the Orthopaedic Community.
    Metsemakers WJ; Zalavras C; Schwarz EM; Chen AF; Trampuz A; Moriarty TF
    J Bone Joint Surg Am; 2021 Jan; 103(1):4-9. PubMed ID: 33259429
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A parallel and silent emerging pandemic: Antimicrobial resistance (AMR) amid COVID-19 pandemic.
    Rehman S
    J Infect Public Health; 2023 Apr; 16(4):611-617. PubMed ID: 36857834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. COVID-19: Clouds Over the Antimicrobial Resistance Landscape.
    Rodríguez-Álvarez M; López-Vidal Y; Soto-Hernández JL; Miranda-Novales MG; Flores-Moreno K; Ponce de León-Rosales S
    Arch Med Res; 2021 Jan; 52(1):123-126. PubMed ID: 33070986
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Physical interventions to interrupt or reduce the spread of respiratory viruses.
    Jefferson T; Dooley L; Ferroni E; Al-Ansary LA; van Driel ML; Bawazeer GA; Jones MA; Hoffmann TC; Clark J; Beller EM; Glasziou PP; Conly JM
    Cochrane Database Syst Rev; 2023 Jan; 1(1):CD006207. PubMed ID: 36715243
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antimicrobial resistance landscape and COVID-19 impact in Egypt, Iraq, Jordan, and Lebanon: A survey-based study and expert opinion.
    Bizri AR; El-Fattah AA; Bazaraa HM; Al Ramahi JW; Matar M; Ali RAN; El Masry R; Moussa J; Abbas AJA; Aziz MA
    PLoS One; 2023; 18(7):e0288550. PubMed ID: 37498951
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Key considerations on the potential impacts of the COVID-19 pandemic on antimicrobial resistance research and surveillance.
    Rodríguez-Baño J; Rossolini GM; Schultsz C; Tacconelli E; Murthy S; Ohmagari N; Holmes A; Bachmann T; Goossens H; Canton R; Roberts AP; Henriques-Normark B; Clancy CJ; Huttner B; Fagerstedt P; Lahiri S; Kaushic C; Hoffman SJ; Warren M; Zoubiane G; Essack S; Laxminarayan R; Plant L
    Trans R Soc Trop Med Hyg; 2021 Oct; 115(10):1122-1129. PubMed ID: 33772597
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antimicrobial Resistance in the COVID-19 Landscape: Is There an Opportunity for Anti-Infective Antibodies and Antimicrobial Peptides?
    Pérez de la Lastra JM; Anand U; González-Acosta S; López MR; Dey A; Bontempi E; Morales delaNuez A
    Front Immunol; 2022; 13():921483. PubMed ID: 35720330
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antimicrobials and antimicrobial resistance genes in the shadow of COVID-19 pandemic: A wastewater-based epidemiology perspective.
    Xu L; Ceolotto N; Jagadeesan K; Standerwick R; Robertson M; Barden R; Kasprzyk-Hordern B
    Water Res; 2024 Jun; 257():121665. PubMed ID: 38692256
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bacterial Epidemiology and Antimicrobial Resistance Profiles in Children Reported by the ISPED Program in China, 2016 to 2020.
    Fu P; Xu H; Jing C; Deng J; Wang H; Hua C; Chen Y; Chen X; Zhang T; Zhang H; Chen Y; Yang J; Lin A; Wang S; Cao Q; Wang X; Deng H; Cao S; Hao J; Gao W; Huang Y; Yu H; Wang C
    Microbiol Spectr; 2021 Dec; 9(3):e0028321. PubMed ID: 34730410
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coronavirus Disease 2019 and Antimicrobial Resistance: Parallel and Interacting Health Emergencies.
    Nieuwlaat R; Mbuagbaw L; Mertz D; Burrows LL; Bowdish DME; Moja L; Wright GD; Schünemann HJ
    Clin Infect Dis; 2021 May; 72(9):1657-1659. PubMed ID: 32544232
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antimicrobial Resistance Threats in the emerging COVID-19 pandemic: Where do we stand?
    Ghosh S; Bornman C; Zafer MM
    J Infect Public Health; 2021 May; 14(5):555-560. PubMed ID: 33848884
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antimicrobial resistance and COVID-19 syndemic: Impact on public health.
    Vidyarthi AJ; Das A; Chaudhry R
    Drug Discov Ther; 2021; 15(3):124-129. PubMed ID: 34234060
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Collateral impacts of pandemic COVID-19 drive the nosocomial spread of antibiotic resistance: A modelling study.
    Smith DRM; Shirreff G; Temime L; Opatowski L
    PLoS Med; 2023 Jun; 20(6):e1004240. PubMed ID: 37276186
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surveillance and prevalence of antimicrobial resistant bacteria from public settings within urban built environments: Challenges and opportunities for hygiene and infection control.
    Cave R; Cole J; Mkrtchyan HV
    Environ Int; 2021 Dec; 157():106836. PubMed ID: 34479136
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibiotic resistance associated with the COVID-19 pandemic: a systematic review and meta-analysis.
    Langford BJ; Soucy JR; Leung V; So M; Kwan ATH; Portnoff JS; Bertagnolio S; Raybardhan S; MacFadden DR; Daneman N
    Clin Microbiol Infect; 2023 Mar; 29(3):302-309. PubMed ID: 36509377
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 66.